The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

The FDA will require Moderna and Pfizer to add warnings to their COVID-19 vaccine labels about myocarditis and pericarditis in young men.

The Food and Drug Administration ... also includes an updated warning regarding the increased risk of myocarditis and pericarditis with mRNA COVID-19 vaccines. The mNexspike vaccine is supplied ...

In the wake of recent warnings from the Food and Drug Administration (FDA), about half of Americans think vaccines against ...

The FDA approved darolutamide (Nubeqa) for metastatic castration-sensitive prostate cancer (mCSPC). The agency previously ...

The shift indicates that critics' efforts to build support by releasing data on the harmful effects of the COVID-19 vaccines ...

Over the weekend, the FDA issued final approval for a new type of vaccine from Moderna, a next generation shot that allows ...

The FDA is also expanding its warning that some vaccines are linked to a risk of heart inflammation in young men.

The Food and Drug Administration has approved a lower-dose COVID-19 vaccine. A new report from The New York Times details ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...